Connection

Co-Authors

This is a "connection" page, showing publications co-authored by STEVEN HSESHENG LIN and BRIAN PAUL HOBBS.
Connection Strength

4.001
  1. Bayesian Group Sequential Clinical Trial Design using Total Toxicity Burden and Progression-Free Survival. J R Stat Soc Ser C Appl Stat. 2016 02; 65(2):273-297.
    View in: PubMed
    Score: 0.530
  2. Radiation-Induced Lymphopenia is a Causal Mediator of Survival After Chemoradiation Therapy for Esophagus Cancer. Adv Radiat Oncol. 2024 Oct; 9(10):101579.
    View in: PubMed
    Score: 0.243
  3. Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal Cancer. Int J Part Ther. 2024 Mar; 11:100012.
    View in: PubMed
    Score: 0.239
  4. Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase 2B Trial of Proton Beam Therapy Versus Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2024 Feb 01; 118(2):368-377.
    View in: PubMed
    Score: 0.228
  5. Declarations of Independence: How Embedded Multicollinearity Errors Affect Dosimetric and Other Complex Analyses in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2023 Dec 01; 117(5):1054-1062.
    View in: PubMed
    Score: 0.226
  6. Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC. JTO Clin Res Rep. 2022 Sep; 3(9):100391.
    View in: PubMed
    Score: 0.212
  7. The Impact of Radiation Dose to Heart Substructures on Major Coronary Events and Patient Survival after Chemoradiation Therapy for Esophageal Cancer. Cancers (Basel). 2022 Mar 03; 14(5).
    View in: PubMed
    Score: 0.206
  8. Current status and application of proton therapy for esophageal cancer. Radiother Oncol. 2021 11; 164:27-36.
    View in: PubMed
    Score: 0.199
  9. Identifying Individualized Risk Profiles for Radiotherapy-Induced Lymphopenia Among Patients With Esophageal Cancer Using Machine Learning. JCO Clin Cancer Inform. 2021 09; 5:1044-1053.
    View in: PubMed
    Score: 0.199
  10. Comparing Radiation Modalities with Trimodality Therapy Using Total Toxicity Burden. Int J Radiat Oncol Biol Phys. 2020 08 01; 107(5):1001-1005.
    View in: PubMed
    Score: 0.184
  11. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer. J Clin Oncol. 2020 05 10; 38(14):1569-1579.
    View in: PubMed
    Score: 0.179
  12. Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC. J Thorac Oncol. 2020 01; 15(1):101-109.
    View in: PubMed
    Score: 0.173
  13. Multimodal Imaging of Pathologic Response to Chemoradiation in Esophageal Cancer. Int J Radiat Oncol Biol Phys. 2018 11 15; 102(4):996-1001.
    View in: PubMed
    Score: 0.156
  14. Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation. Int J Part Ther. 2018; 4(3):23-32.
    View in: PubMed
    Score: 0.154
  15. Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. Radiother Oncol. 2018 07; 128(1):154-160.
    View in: PubMed
    Score: 0.154
  16. RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer. Clin Cancer Res. 2018 01 15; 24(2):341-350.
    View in: PubMed
    Score: 0.152
  17. Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):325-332.
    View in: PubMed
    Score: 0.146
  18. Definitive Chemoradiation Therapy for Esophageal Cancer in the Elderly: Clinical Outcomes for Patients Exceeding 80?Years Old. Int J Radiat Oncol Biol Phys. 2017 07 15; 98(4):811-819.
    View in: PubMed
    Score: 0.145
  19. Clinical Translation of a Deep Learning Model of Radiation-Induced Lymphopenia for Esophageal Cancer. Int J Part Ther. 2024 Sep; 13:100624.
    View in: PubMed
    Score: 0.061
  20. Personalized Composite Dosimetric Score-Based Machine Learning Model of Severe Radiation-Induced Lymphopenia Among Patients With Esophageal Cancer. Int J Radiat Oncol Biol Phys. 2024 Nov 15; 120(4):1172-1180.
    View in: PubMed
    Score: 0.060
  21. An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and Atherosclerosis. Circ Res. 2023 06 23; 133(1):25-44.
    View in: PubMed
    Score: 0.056
  22. A hybrid deep learning model for forecasting lymphocyte depletion during radiation therapy. Med Phys. 2022 May; 49(5):3507-3522.
    View in: PubMed
    Score: 0.052
  23. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Respir Med. 2021 05; 9(5):467-475.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.